BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9635678)

  • 21. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgV(H) and bcl6 somatic mutation analysis reveals the heterogeneity of cutaneous B-cell lymphoma, and indicates the presence of undisclosed local antigens.
    Franco R; Camacho FI; Fernández-Vázquez A; Algara P; Rodríguez-Peralto JL; De Rosa G; Piris MA
    Mod Pathol; 2004 Jun; 17(6):623-30. PubMed ID: 15098010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments.
    Perez M; Pacchiarotti A; Frontani M; Pescarmona E; Caprini E; Lombardo GA; Russo G; Faraggiana T
    Br J Dermatol; 2010 Mar; 162(3):611-8. PubMed ID: 19906071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
    Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
    Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH.
    Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D
    Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
    Troussard X; Cornet E
    Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
    Catovsky D; Matutes E
    Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA sequences of the immunoglobulin heavy chain variable region gene in pyothorax-associated lymphoma.
    Miwa H; Takakuwa T; Nakatsuka S; Tomita Y; Iuchi K; Aozasa K
    Oncology; 2002; 62(3):241-50. PubMed ID: 12065872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
    Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
    Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma.
    Hara Y; Nakamura N; Kuze T; Hashimoto Y; Sasaki Y; Shirakawa A; Furuta M; Yago K; Kato K; Abe M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2450-7. PubMed ID: 11581182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
    Coupland SE; Hummel M; Müller HH; Stein H
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodal and splenic marginal zone B cell lymphomas.
    Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
    Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.
    Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E
    Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.
    Sol Mateo M; Mollejo M; Villuendas R; Algara P; Sánchez-Beato M; Martinez-Delgado B; Martínez P; Piris MA
    Mol Pathol; 1998 Oct; 51(5):262-7. PubMed ID: 10193520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
    Granai M; Amato T; Di Napoli A; Santi R; Vergoni F; Di Stefano G; Mancini V; Kovalchuk S; Cencini E; Carta AG; Aversa S; Ziepert M; Cevenini G; Lazzi S; Leoncini L; Bellan C
    Virchows Arch; 2020 Jul; 477(1):143-150. PubMed ID: 31802229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type.
    Pham-Ledard A; Prochazkova-Carlotti M; Deveza M; Laforet MP; Beylot-Barry M; Vergier B; Parrens M; Feuillard J; Merlio JP; Gachard N
    J Dermatol Sci; 2017 Nov; 88(2):238-246. PubMed ID: 28838616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets.
    Tierens A; Delabie J; Pittaluga S; Driessen A; DeWolf-Peeters C
    Blood; 1998 Apr; 91(7):2381-6. PubMed ID: 9516137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splenic marginal zone lymphoma.
    Oscier D; Owen R; Johnson S
    Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
    Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
    Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.